1 |
Morin PJ. 1999. -catenin signaling and cancer. Bioessays 21: 1021-1030.
DOI
ScienceOn
|
2 |
Matsuzawa SI, Reed JC. 2001. Siah-1, SIP, and Ebi collaborate in a novel pathway for -catenin degradation linked to p53 responses. Mol. Cell 7: 915-926.
DOI
ScienceOn
|
3 |
Miller JR. 2002. The Wnts. Genome Biol. 3: reviews3001.1- reviews3001.15.
|
4 |
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. 1997. Activation of -catenin-Tcf signaling in colon cancer by mutations in -catenin or APC. Science 275: 1787-1790.
DOI
ScienceOn
|
5 |
Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. 1997. Serine phosphorylation-regulated ubquitination and degradation of -catenin. J. Biol. Chem. 272: 24735-24738.
DOI
|
6 |
Pettit GR, Herald CL, Doubek DL, Herald DL, Arnold E, Clardy J. 1982. Isolation and structure of bryostatin 1. J. Am. Chem. Soc. 104: 6846-6848.
DOI
|
7 |
Polakis P. 2002. Casein kinase 1: a Wnt'er of disconnect. Curr. Biol. 12: R499-R501.
DOI
ScienceOn
|
8 |
Shaha SP, Tomic J, Shi Y, Pham T, Mero P, White D, et al. 2009. Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells. Clin. Exp. Immunol. 158: 186-198.
DOI
|
9 |
Sun MK, Alkon DL. 2005. Dual effects of bryostatin-1 on spatial memory and depression. Eur. J. Pharm. 512: 43-51.
DOI
|
10 |
Takahashi M, Tsunoda T, Seiki M, Nakamura Y, Furukawa Y. 2002. Identification of membrane-type matrix metalloproteinase- 1 as a target of the -catenin/Tcf4 complex in human colorectal cancers. Oncogene 21: 5861-5867.
DOI
ScienceOn
|
11 |
Tetsu O, McCormick F. 1999. -catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
DOI
ScienceOn
|
12 |
Hale KJ, Hummersone MG, Manaviazar S, Frigerio M. 2002. The chemistry and biology of the bryostatin antitumour macrolides. Nat. Prod. Rep. 19: 413-453.
DOI
|
13 |
Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475- 1489.
DOI
ScienceOn
|
14 |
Fearnhead NS, Britton MP, Bodmer WF. 2001. The ABC of APC. Hum. Mol. Genet. 10: 721-733.
DOI
ScienceOn
|
15 |
Giles RH, van Es JH, Clevers H. 2003. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta. 1653: 1-24.
|
16 |
He TC, Chan TA, Vogelstein B, Kinzler KW. 1999. PPARO is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345.
DOI
ScienceOn
|
17 |
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509- 1512.
DOI
ScienceOn
|
18 |
Jaggi M, Chauhan SC, Du C, Balaji KC. 2008. Bryostatin 1 modulates -catenin subcellular localization and transcription activity through protein kinase D1 activation. Mol. Cancer Ther. 7: 2703-271.
DOI
|
19 |
Karim R, Tse G, Putti T, Scolyer R, Lee S. 2004. The significance of the Wnt pathway in the pathology of human cancers. Pathology 36: 120-128.
DOI
|
20 |
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. 1997. Constitutive transcriptional activation by a -catenin-Tcf complex in APC -/- colon carcinoma. Science 275: 1784-1787.
DOI
ScienceOn
|
21 |
Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW. 2003. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 1: 116-132.
|
22 |
Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, et al. 2001. Siah-1 mediates a novel -catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell 7: 927-936.
DOI
ScienceOn
|
23 |
Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. 1997. - Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16: 3797-3804.
DOI
ScienceOn
|